Author
Listed:
- Yuka Kotozaki
(Iwate Tohoku Medical Megabank Organization, Iwate Medical University, Yahaba 028-3694, Japan)
- Mamoru Satoh
(Iwate Tohoku Medical Megabank Organization, Iwate Medical University, Yahaba 028-3694, Japan
Division of Biomedical Information Analysis, Institute for Biomedical Sciences, Iwate Medical University, Yahaba 028-3694, Japan)
- Kozo Tanno
(Iwate Tohoku Medical Megabank Organization, Iwate Medical University, Yahaba 028-3694, Japan
Department of Hygiene and Preventive Medicine, Iwate Medical University, Yahaba 028-3694, Japan)
- Hideki Ohmomo
(Iwate Tohoku Medical Megabank Organization, Iwate Medical University, Yahaba 028-3694, Japan)
- Ryo Otomo
(Iwate Tohoku Medical Megabank Organization, Iwate Medical University, Yahaba 028-3694, Japan)
- Fumitaka Tanaka
(Iwate Tohoku Medical Megabank Organization, Iwate Medical University, Yahaba 028-3694, Japan
Division of Nephrology and Hypertension, Department of Internal Medicine, Iwate Medical University, Yahaba 028-3694, Japan)
- Takahito Nasu
(Iwate Tohoku Medical Megabank Organization, Iwate Medical University, Yahaba 028-3694, Japan
Division of Biomedical Information Analysis, Institute for Biomedical Sciences, Iwate Medical University, Yahaba 028-3694, Japan
Division of Cardiology, Department of Internal Medicine, Iwate Medical University, Yahaba 028-3694, Japan)
- Satoru Taguchi
(Division of Cardiology, Department of Internal Medicine, Iwate Medical University, Yahaba 028-3694, Japan)
- Hiroto Kikuchi
(Division of Cardiology, Department of Internal Medicine, Iwate Medical University, Yahaba 028-3694, Japan)
- Takamasa Kobayashi
(Division of Cardiology, Department of Internal Medicine, Iwate Medical University, Yahaba 028-3694, Japan)
- Atsushi Shimizu
(Iwate Tohoku Medical Megabank Organization, Iwate Medical University, Yahaba 028-3694, Japan
Division of Biomedical Information Analysis, Institute for Biomedical Sciences, Iwate Medical University, Yahaba 028-3694, Japan)
- Kiyomi Sakata
(Iwate Tohoku Medical Megabank Organization, Iwate Medical University, Yahaba 028-3694, Japan
Department of Hygiene and Preventive Medicine, Iwate Medical University, Yahaba 028-3694, Japan)
- Jiro Hitomi
(Iwate Tohoku Medical Megabank Organization, Iwate Medical University, Yahaba 028-3694, Japan
Department of Anatomy, Iwate Medical University, Yahaba 028-3694, Japan)
- Kenji Sobue
(Department of Neuroscience, Institute for Biomedical Sciences, Iwate Medical University, Yahaba 028-3694, Japan)
- Makoto Sasaki
(Iwate Tohoku Medical Megabank Organization, Iwate Medical University, Yahaba 028-3694, Japan
Division of Ultrahigh field MRI, Institute for Biomedical Sciences, Iwate Medical University, Yahaba 028-3694, Japan)
Abstract
The purpose of this study was to investigate the association between xanthine oxidoreductase (XOR) activity and a high risk of cardiovascular disease (CVD) in a general Japanese population. The Iwate Tohoku Medical Megabank Organization pooled individual participant data from a general population-based cohort study in Iwate prefecture. The cardiovascular risk was calculated using the Framingham Risk Score (FRS). A total of 1605 of the 1631 participants (98.4%) had detectable XOR activity. Multiple regression analysis demonstrated that XOR activity was independently associated with body mass index (β = 0.26, p < 0.001), diabetes (β = 0.09, p < 0.001), dyslipidemia (β = 0.08, p = 0.001), and uric acid (β = 0.13, p < 0.001). Multivariate analysis showed that the highest quartile of XOR activity was associated with a high risk for CVD (FRS ≥ 15) after adjustment for baseline characteristics (OR 2.93, 95% CI 1.16–7.40). The area under the receiver operating characteristic curves of the FRS with XOR activity was 0.81 ( p = 0.008). XOR activity is associated with a high risk for CVD, suggesting that high XOR activity may indicate cardiovascular risk in a general Japanese population.
Suggested Citation
Yuka Kotozaki & Mamoru Satoh & Kozo Tanno & Hideki Ohmomo & Ryo Otomo & Fumitaka Tanaka & Takahito Nasu & Satoru Taguchi & Hiroto Kikuchi & Takamasa Kobayashi & Atsushi Shimizu & Kiyomi Sakata & Jiro , 2021.
"Plasma Xanthine Oxidoreductase Activity Is Associated with a High Risk of Cardiovascular Disease in a General Japanese Population,"
IJERPH, MDPI, vol. 18(4), pages 1-10, February.
Handle:
RePEc:gam:jijerp:v:18:y:2021:i:4:p:1894-:d:500140
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:4:p:1894-:d:500140. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.